Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Rep. Buddy Carter is running an ad in Atlanta for his Senate campaign, saying he’s trusted by both conservatives and President Donald Trump.

Georgia GOP Reps. Carter and Collins weigh Senate runs

News: Sen. Jim Banks (R-Ind.) and Rep. Frank Mrvan (D-Ind.) wrote a letter to Treasury Secretary Scott Bessent about the importance of a “strong, domestically owned and operated American steel industry.” Nippon Steel, of course, is interested in buying U.S. steel.

Senate news: Rep. Robin Kelly (D-Ill.) is running for Senate, joining a growing field of ambitious Democrats seeking to succeed retiring Sen. Dick Durbin (D-Ill.). Kelly, 69, was first elected to the House in 2013 and has focused on gun safety and maternal health issues.

Peach State: The Georgia delegation is already jockeying for who will be the best GOP candidate to take on Sen. Jon Ossoff (D-Ga.) after Gov. Brian Kemp passed on a run.

Georgia GOP Reps. Buddy Carter and Mike Collins put out lengthy statements Monday night saying they’re weighing possible runs. Collins said he will speak to President Donald Trump about it.

“I’m looking forward to getting in there and helping,” Collins told us. “That’s a seat we can win.”

Rep. Marjorie Taylor Greene (R-Ga.), a close Trump ally, told us she’s keeping her options open, adding she has “a lot of great support in Georgia.”

Meanwhile, Rep. Rick Allen (R-Ga.) said he’d jump in if Trump asked him to, and there’s speculation that Rep. Rich McCormick (R-Ga.) could be interested too.

One member we can rule out, however, is senior Georgia GOP Rep. Austin Scott, who says he has “no intentions at this time” to run for Senate.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.